Similar articles

• Protease inhibitors for prevention of ERCP pancreatitis: can we afford the price of success?

  Ziebert JJ, Bjorkman DJ. Ziebert JJ, et al. Am J Gastroenterol. 1997 Jun;92(6):1067-8. Am J Gastroenterol. 1997. PMID: 9177543 No abstract available.
• Frequency of post-ERCP pancreatitis in a single tertiary referral centre without and with routine prophylaxis with gabexate: a 6-year survey and cost-effectiveness analysis.

  Testoni PA, Mariani A, Masci E, Curioni S. Testoni PA, et al. Dig Liver Dis. 2006 Aug;38(8):588-95. doi: 10.1016/j.dld.2006.04.001. Epub 2006 May 30. Dig Liver Dis. 2006. PMID: 16731060
• Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.

  Zheng M, Chen Y, Yang X, Li J, Zhang Y, Zeng Q. Zheng M, et al. BMC Gastroenterol. 2007 Feb 12;7:6. doi: 10.1186/1471-230X-7-6. BMC Gastroenterol. 2007. PMID: 17295917 Free PMC article.
• [Can post-ERCP acute pancreatitis be predicted and prevented?].

  Heyries L. Heyries L. Gastroenterol Clin Biol. 2001 Jan;25(1 Suppl):1S241-6. Gastroenterol Clin Biol. 2001. PMID: 11223596 Review. French. No abstract available.
• Antiproteases in preventing post-ERCP acute pancreatitis.

  Tsujino T, Kawabe T, Omata M. Tsujino T, et al. JOP. 2007 Jul 9;8(4 Suppl):509-17. JOP. 2007. PMID: 17625308 Review.